Search

Your search keyword '"Nieman, Linda T."' showing total 265 results

Search Constraints

Start Over You searched for: Author "Nieman, Linda T." Remove constraint Author: "Nieman, Linda T."
265 results on '"Nieman, Linda T."'

Search Results

1. Immune responses in checkpoint myocarditis across heart, blood and tumour

2. Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis

Catalog

Books, media, physical & digital resources

3. Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy

4. Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer

5. Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms

6. Selective targeting of MYC mRNA by stabilized antisense oligonucleotides

8. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer

9. Supplementary Video S12 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

10. Supplementary Figure S6 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

11. Data from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

12. Supplementary Methods 1 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

13. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer

14. Spatially organized multicellular immune hubs in human colorectal cancer

15. Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype

16. Supplementary Figure 6 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

17. Supplementary Figure 24 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

18. Supplementary Figure 5 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

19. Supplementary Figure 17 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

20. Supplementary Tables S1-S12 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

21. Supplementary Figure 9 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

22. Supplementary Figure 7 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

23. Supplementary Data 1 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

24. Data from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

25. Supplementary Figure 4 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

26. Supplementary Data 2 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

27. Supplementary Figure 8 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

28. Supplementary Figure 3 from Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

29. Dysregulated Repeat Element Viral-like Immune Response in Hepatocellular Carcinoma

30. Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy

31. Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

32. Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker

33. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection

34. HIF1A signaling selectively supports proliferation of breast cancer in the brain

36. Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response

37. Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

38. Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

39. Supplementary Figure from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

40. Table S2 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

41. Data from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

42. Supplementary Data from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

43. Abstract PR004: Characterizing the effects of neoadjuvant therapy in PDAC

44. Abstract A066: 5z-7-oxozeaenol as an epithelial mesenchymal transition plasticity inhibitor in PDAC

47. Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

48. Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition

49. Active RB causes visible changes in nuclear organization

50. Altered interactions between circulating and tissue-resident CD8 T cells with the colonic mucosa define colitis associated with immune checkpoint inhibitors